Articles with public access mandates - Charlie MassieLearn more
OverallCancer Research UKNIHRMRCWellcomeNIHEuropean CommissionProstate Cancer UKCIHRAcademy of FinlandBBSRCBlood Cancer UKDoDNHMRCFWOFWFINSERMBMBFSNSFGenome CanadaNSERCPCCDFGDSFNWOFCTSwedish Research CouncilVersus Arthritis, UKEPSRCRCNTarget Ovarian Cancer, UKGovernment of ItalyBrain Tumour Charity, UKHealth Data Research, UKHFSPOICR
Not available anywhere: 3
PD49-04 ACCURATE DIFFERENTIATION OF PATHOLOGICAL SUBTYPES OF RENAL TUMOUR BY APPLYING A MACHINE LEARNING MODEL TO EPIGENETIC MARKERS
S Rossi, I Newsham, S Pita, G Park, R Lach, A Babbage, C Smith, ...
Journal of Urology 206 (Supplement 3), e846, 2021
Mandates: Cancer Research UK
MP18-14 CHARACTERISING DNA METHYLATION PATTERNS IN TISSUE AND CIRCULATING TUMOUR DNA TO ENABLE DIFFERENTIATION OF SMALL RENAL MASSES
S Rossi, S Pita, A Babbage, G Park, R Lach, C Smith, K Brennan, ...
Journal of Urology 203, e240-e241, 2020
Mandates: Cancer Research UK
DETECTION OF PRIVATE CLONAL MUTATIONS IN LOCALISED PROSTATE CANCER FROM RARE MOLECULES OF CIRCULATING TUMOUR DNA: PD56-03
K Patel, C Massie, F Marass, J Morris, A Lynch, F Mouliere, D Neal, ...
Journal of Urology 199 (4), e1062-e1063, 2018
Mandates: European Commission
Available somewhere: 73
Liquid biopsies come of age: towards implementation of circulating tumour DNA
JCM Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, ...
Nature Reviews Cancer 17 (4), 223-238, 2017
Mandates: Cancer Research UK, National Institute for Health Research, UK, European …
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
J Nangalia, CE Massie, EJ Baxter, FL Nice, G Gundem, DC Wedge, ...
New England Journal of Medicine 369 (25), 2391-2405, 2013
Mandates: Research Foundation (Flanders), Canadian Institutes of Health Research …
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
Mandates: US National Institutes of Health
Enhanced detection of circulating tumor DNA by fragment size analysis
F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ...
Science translational medicine 10 (466), eaat4921, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Engineering and …
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
Mandates: Cancer Research UK
Effect of mutation order on myeloproliferative neoplasms
CA Ortmann, DG Kent, J Nangalia, Y Silber, DC Wedge, J Grinfeld, ...
New England Journal of Medicine 372 (7), 601-612, 2015
Mandates: Canadian Institutes of Health Research, German Research Foundation, Blood …
Classification and personalized prognosis in myeloproliferative neoplasms
J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, ...
New England Journal of Medicine 379 (15), 1416-1430, 2018
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK, UK …
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
CS Cooper, R Eeles, DC Wedge, P Van Loo, G Gundem, LB Alexandrov, ...
Nature genetics 47 (4), 367-372, 2015
Mandates: Research Foundation (Flanders), UK Biotechnology and Biological Sciences …
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
NL Sharma, CE Massie, A Ramos-Montoya, V Zecchini, HE Scott, ...
Cancer cell 23 (1), 35-47, 2013
Mandates: Cancer Research UK
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ...
elife 3, e02935, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
CE Massie, B Adryan, NL Barbosa‐Morais, AG Lynch, MG Tran, DE Neal, ...
EMBO reports 8 (9), 871-878, 2007
Mandates: Cancer Research UK
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
CS Ross-Innes, R Stark, KA Holmes, D Schmidt, C Spyrou, R Russell, ...
Genes & development 24 (2), 171-182, 2010
Mandates: Cancer Research UK
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
M Asim, F Tarish, HI Zecchini, K Sanjiv, E Gelali, CE Massie, A Baridi, ...
Nature communications 8 (1), 374, 2017
Mandates: Swedish Research Council, Cancer Research UK, UK Medical Research Council …
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel
AA Ahmed, AD Mills, AEK Ibrahim, J Temple, C Blenkiron, M Vias, ...
Cancer cell 12 (6), 514-527, 2007
Mandates: Cancer Research UK
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
DC Wedge, G Gundem, T Mitchell, DJ Woodcock, I Martincorena, M Ghori, ...
Nature genetics 50 (5), 682-692, 2018
Mandates: US National Institutes of Health, Academy of Finland, Cancer Research UK …
Inactivating CUX1 mutations promote tumorigenesis
CC Wong, I Martincorena, AG Rust, M Rashid, C Alifrangis, ...
Nature genetics 46 (1), 33-38, 2014
Mandates: Cancer Research UK, UK Medical Research Council, Wellcome Trust, European …
Publication and funding information is determined automatically by a computer program